UroGen Pharma Ltd.
NASDAQ:URGN
12.12 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q1 | 2014 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 25.204 | 21.848 | 18.781 | 23.53 | 20.852 | 21.139 | 17.192 | 18.092 | 16.097 | 16.604 | 13.564 | 16.174 | 11.351 | 13.032 | 7.485 | 7.966 | 3.461 | 0.372 | 0 | 0 | 0 | 0.018 | 0 | 0 | 0.283 | 0.364 | 0.481 | 0.327 | 7.812 | 0 | 0.019 | 17.53 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 2.453 | 2.229 | 1.728 | 2.286 | 2.367 | 2.443 | 2.265 | 2.263 | 2.02 | 1.846 | 1.525 | 1.589 | 1.244 | 1.427 | 0.897 | 0.652 | 0.309 | 0.048 | 0 | 0 | 23.453 | 0 | 22.433 | 0 | 1.055 | 0.318 | 0.43 | 0.287 | 0.295 | 0 | 0.018 | 0.028 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 22.751 | 19.619 | 17.053 | 21.244 | 18.485 | 18.696 | 14.927 | 15.829 | 14.077 | 14.758 | 12.039 | 14.585 | 10.107 | 11.605 | 6.588 | 7.314 | 3.152 | 0.324 | 0 | 0 | -23.453 | 0.018 | -22.433 | 0 | -0.772 | 0.046 | 0.051 | 0.04 | 7.517 | 0 | 0.001 | 17.502 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.903 | 0.898 | 0.908 | 0.903 | 0.886 | 0.884 | 0.868 | 0.875 | 0.875 | 0.889 | 0.888 | 0.902 | 0.89 | 0.891 | 0.88 | 0.918 | 0.911 | 0.871 | 0 | 0 | 0 | 1 | 0 | 0 | -2.728 | 0.126 | 0.106 | 0.122 | 0.962 | 0 | 0.053 | 0.998 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 11.355 | 15.402 | 15.494 | 11.302 | 10.23 | 11.584 | 12.498 | 14.477 | 13.093 | 12.64 | 12.696 | 13.082 | 11.923 | 12.124 | 10.513 | 12.405 | 10.211 | 8.106 | 16.588 | 20.094 | 9.481 | 9.996 | 9.726 | 11.465 | 9.574 | 8.273 | 7.622 | 6.761 | 5.621 | 3.651 | 2.664 | 2.372 | 2.873 | 2.351 | 2.806 | 7.238 | 1.84 | 1.443 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39.943 | 0 | 0 | 0 | 22.163 | 0 | 24.018 | 21.973 | 19.745 | 13.972 | 13.775 | 12.707 | 12.552 | 10.743 | 10.207 | 6.069 | 3.437 | 2.199 | 2.3 | 0.875 | 1.229 | 3.237 | 1.044 | 0.907 | 0.886 | 0.194 | 0.281 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47.592 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 28.941 | 30.056 | 27.299 | 24.551 | 21.755 | 22.494 | 24.474 | 21.634 | 19.071 | 20.833 | 21.3 | 21.418 | 21.624 | 22.304 | 22.189 | 22.163 | 22.065 | 24.018 | 21.973 | 19.745 | 13.972 | 13.775 | 12.707 | 12.552 | 10.743 | 10.207 | 6.069 | 3.437 | 2.199 | 2.3 | 0.875 | 1.229 | 3.237 | 1.044 | 0.907 | 0.886 | 0.194 | 0.281 |
| Other Expenses
| 0 | -0.014 | -0.183 | 0.812 | 0.071 | -0.03 | -0.015 | 0 | 0.037 | 0 | -0.004 | -66.117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 40.296 | 45.458 | 42.793 | 35.853 | 31.985 | 34.078 | 36.972 | 36.111 | 32.164 | 33.473 | 33.996 | 34.5 | 33.547 | 34.428 | 32.702 | 34.568 | 32.276 | 32.124 | 38.561 | 39.839 | 23.453 | 23.771 | 22.433 | 24.017 | 20.317 | 18.48 | 13.691 | 10.198 | 7.82 | 5.951 | 3.539 | 3.601 | 6.11 | 3.395 | 3.598 | 7.029 | 2.034 | 1.182 |
| Operating Income
| -17.545 | -25.839 | -25.74 | -14.609 | -13.5 | -15.382 | -22.045 | -20.282 | -18.087 | -18.715 | -21.957 | -19.915 | -23.44 | -22.823 | -26.114 | -27.254 | -29.124 | -31.8 | -38.561 | -39.839 | -23.453 | -23.753 | -22.433 | -24.017 | -21.089 | -18.434 | -13.64 | -10.158 | -0.303 | -5.951 | -3.538 | 13.901 | -6.11 | -3.395 | -3.598 | -6.963 | -2.034 | -1.195 |
| Operating Income Ratio
| -0.696 | -1.183 | -1.371 | -0.621 | -0.647 | -0.728 | -1.282 | -1.121 | -1.124 | -1.127 | -1.619 | -1.231 | -2.065 | -1.751 | -3.489 | -3.421 | -8.415 | -85.484 | 0 | 0 | 0 | -1,319.611 | 0 | 0 | -74.519 | -50.643 | -28.358 | -31.064 | -0.039 | 0 | -186.211 | 0.793 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -6.037 | -7.526 | -6.492 | -7.553 | -5.408 | -5.344 | -8.147 | -7.898 | -7.035 | -7.944 | -6.11 | -7.343 | -6.828 | -3.12 | 0.179 | 0.102 | 0.308 | 0.451 | 0.768 | 0.866 | 1.201 | 1.276 | 0.989 | 0.425 | 0.556 | 0.408 | -0.1 | 0.091 | 0.005 | -0.248 | 0.121 | -0.978 | -1.877 | 0.078 | 0.038 | -0.074 | -0.011 | -0.006 |
| Income Before Tax
| -23.582 | -33.365 | -32.232 | -22.162 | -21.888 | -24.082 | -30.192 | -28.18 | -25.122 | -26.659 | -28.067 | -27.315 | -30.211 | -25.91 | -25.935 | -27.152 | -28.816 | -31.349 | -37.793 | -38.973 | -22.252 | -22.477 | -21.444 | -23.592 | -20.533 | -18.026 | -13.382 | -10.067 | -0.298 | -6.199 | -3.417 | 12.923 | -7.987 | -3.317 | -3.56 | -7.037 | -2.045 | -1.201 |
| Income Before Tax Ratio
| -0.936 | -1.527 | -1.716 | -0.942 | -1.05 | -1.139 | -1.756 | -1.558 | -1.561 | -1.606 | -2.069 | -1.689 | -2.662 | -1.988 | -3.465 | -3.408 | -8.326 | -84.272 | 0 | 0 | 0 | -1,248.722 | 0 | 0 | -72.555 | -49.522 | -27.821 | -30.786 | -0.038 | 0 | -179.842 | 0.737 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.091 | 0.038 | 0.054 | 3.854 | -0.009 | 0.054 | 0.021 | 0.069 | 0.709 | 0.032 | 0.325 | 1.137 | 6.771 | 0.312 | 0 | 3.374 | 0 | 0 | 0 | 0 | -0.245 | -0.246 | -0.245 | 0.125 | 0 | 0 | -0.258 | 0.019 | 0 | 0 | 0 | 0.622 | 0 | 0 | 0.602 | 0.393 | 0.1 | 0.081 |
| Net Income
| -23.673 | -33.403 | -32.286 | -26.016 | -21.879 | -24.136 | -30.213 | -28.249 | -25.831 | -26.691 | -28.392 | -28.452 | -30.211 | -26.222 | -25.935 | -30.526 | -28.816 | -31.349 | -37.793 | -38.973 | -22.252 | -22.477 | -21.444 | -23.717 | -20.533 | -18.026 | -13.382 | -10.067 | -0.298 | -6.199 | -3.417 | 12.301 | -7.987 | -3.317 | -4.162 | -7.43 | -2.145 | -1.282 |
| Net Income Ratio
| -0.939 | -1.529 | -1.719 | -1.106 | -1.049 | -1.142 | -1.757 | -1.561 | -1.605 | -1.608 | -2.093 | -1.759 | -2.662 | -2.012 | -3.465 | -3.832 | -8.326 | -84.272 | 0 | 0 | 0 | -1,248.722 | 0 | 0 | -72.555 | -49.522 | -27.821 | -30.786 | -0.038 | 0 | -179.842 | 0.702 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -5.49 | -0.91 | -0.97 | -0.72 | -0.68 | -1.03 | -1.3 | -1.22 | -1.13 | -1.18 | -1.25 | -1.27 | -1.35 | -1.17 | -1.17 | -1.38 | -1.31 | -1.44 | -1.79 | -1.86 | -1.06 | -1.08 | -1.11 | -1.46 | -1.28 | -1.14 | -0.88 | -0.74 | -0.023 | -0.67 | -0.31 | 1.18 | -0.67 | -0.28 | -1.81 | -3.23 | -0.93 | -0.56 |
| EPS Diluted
| -5.49 | -0.91 | -0.97 | -0.72 | -0.68 | -1.03 | -1.3 | -1.22 | -1.13 | -1.18 | -1.25 | -1.27 | -1.35 | -1.17 | -1.17 | -1.38 | -1.31 | -1.44 | -1.79 | -1.84 | -1.06 | -1.08 | -1.11 | -1.46 | -1.28 | -1.14 | -0.88 | -0.74 | -0.023 | -0.67 | -0.31 | 1.18 | -0.67 | -0.28 | -1.81 | -3.23 | -0.93 | -0.56 |
| EBITDA
| -17.545 | -25.576 | -25.389 | -14.185 | -12.179 | -14.546 | -20.98 | -19.876 | -17.174 | -18.111 | -21.503 | -19.915 | -16.16 | -19.261 | -25.686 | -27.254 | -28.626 | -31.325 | -38.105 | -38.703 | -23.388 | -23.693 | -22.37 | -24.017 | -21.031 | -18.383 | -13.3 | -10.158 | -0.286 | -5.864 | -3.493 | 13.982 | -6.053 | -3.357 | -3.561 | -6.928 | -2.016 | -1.187 |
| EBITDA Ratio
| -0.696 | -1.171 | -1.352 | -0.603 | -0.584 | -0.688 | -1.22 | -1.099 | -1.067 | -1.091 | -1.585 | -1.231 | -1.424 | -1.478 | -3.432 | -3.421 | -8.271 | -84.207 | 0 | 0 | 0 | -1,316.278 | 0 | 0 | -74.314 | -50.503 | -27.651 | -31.064 | -0.037 | 0 | -183.842 | 0.798 | 0 | 0 | 0 | 0 | 0 | 0 |